checkAd
    Startseite > Aktien > Neuronetics > Nachrichten
    Neuronetics Aktie
    3,2725
     
    EUR
    +2,27 %
    +0,0725 EUR
    Letzter Kurs 11:42:27 Lang & Schwarz
    3,1550
     
    EUR
    1.947 STK
    Geldkurs 11:42:27
    3,3900
     
    EUR
    1.947 STK
    Briefkurs 11:42:27
    ISIN: US64131A1051 · WKN: A2JPMY · USA

    Neueste Nachrichten

    Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
    23.04.24 · globenewswire · Neuronetics
    New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
    10.04.24 · globenewswire · Neuronetics
    Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    27.03.24 · globenewswire · Neuronetics
    NeuroStar Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
    25.03.24 · globenewswire · Neuronetics
    Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
    07.03.24 · globenewswire · Neuronetics
    Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
    05.03.24 · globenewswire · Neuronetics
    Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
    20.02.24 · globenewswire · Neuronetics
    Neuronetics Launches Latest Evolution in its TrakStar Patient Data Management System
    12.02.24 · globenewswire · Neuronetics
    NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
    06.02.24 · globenewswire · Neuronetics
    Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
    08.01.24 · globenewswire · Neuronetics
    Neuronetics Receives 510(k) Clearance for NeuroSite Coil Placement Accessory
    18.12.23 · globenewswire · Neuronetics
    Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
    15.11.23 · globenewswire · Neuronetics